CareDx (CDNA) Tops Q2 EPS by 20c
Get Alerts CDNA Hot Sheet
Join SI Premium – FREE
CareDx (NASDAQ: CDNA) reported Q2 EPS of $0.10, $0.20 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $86.7 million versus the consensus estimate of $90.62 million.
For earnings history and earnings-related data on CareDx (CDNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- Therma Bright plans $420,000 non-brokered private placement
- Goldman Sachs sees US stocks dip on tech earnings and macro shifts
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share